Caliber Imaging & Diagnostics Inc
Caliber Imaging & Diagnostics, Inc., a medical technologies company, designs, develops, and markets imaging solutions that shows tissue at the cellular level in the United States. The company provides VivaScope 1500, a reflectance confocal imaging system that enables clinicians and researchers to capture confocal images that depict cellular structures of living tissue; and VivaScope 3000, a hand-… Read more
Caliber Imaging & Diagnostics Inc (LCDX) - Net Assets
Latest net assets as of March 2014: $-14.18 Million USD
Based on the latest financial reports, Caliber Imaging & Diagnostics Inc (LCDX) has net assets worth $-14.18 Million USD as of March 2014.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($2.21 Million) and total liabilities ($16.40 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-14.18 Million |
| % of Total Assets | -640.88% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Caliber Imaging & Diagnostics Inc - Net Assets Trend (2009–2013)
This chart illustrates how Caliber Imaging & Diagnostics Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Caliber Imaging & Diagnostics Inc (2009–2013)
The table below shows the annual net assets of Caliber Imaging & Diagnostics Inc from 2009 to 2013.
| Year | Net Assets | Change |
|---|---|---|
| 2013-12-31 | $-12.49 Million | -62.10% |
| 2012-12-31 | $-7.71 Million | -1058.62% |
| 2011-12-31 | $-665.22K | +92.10% |
| 2010-12-31 | $-8.42 Million | +7.81% |
| 2009-12-31 | $-9.14 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Caliber Imaging & Diagnostics Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 2865655700.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2013)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $85.07K | % |
| Other Components | $39.37 Million | % |
| Total Equity | $-12.49 Million | 100.00% |
Caliber Imaging & Diagnostics Inc Competitors by Market Cap
The table below lists competitors of Caliber Imaging & Diagnostics Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
InRob Tech Ltd
PINK:IRBL
|
$0.93 |
|
Cygnus Oil & Gas Corp
PINK:CYNS
|
$0.93 |
|
Syntrol Corp
PINK:SNLP
|
$0.93 |
|
Sharpe Resources Corporation
PINK:SHGP
|
$0.93 |
|
MotorVac Technologies Inc
PINK:MVAC
|
$0.93 |
|
Neurogenesis Inc
PINK:NEUN
|
$0.93 |
|
Exobox Tech Corp
PINK:EXBX
|
$0.93 |
|
Next.e.GO N.V.
NASDAQ:EGOXF
|
$0.93 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Caliber Imaging & Diagnostics Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2012 to 2013, total equity changed from -7,707,355 to -12,493,271, a change of -4,785,916.
- Net loss of 5,479,251 reduced equity.
- Other factors increased equity by 693,335.
Equity Change Factors (2012 to 2013)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-5.48 Million | -43.86% |
| Other Changes | $693.34K | +5.55% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Caliber Imaging & Diagnostics Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2009-12-31 | $-4.22 | $0.00 | x |
| 2010-12-31 | $-3.89 | $0.00 | x |
| 2011-12-31 | $-0.31 | $0.00 | x |
| 2012-12-31 | $-0.96 | $0.00 | x |
| 2013-12-31 | $-1.49 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Caliber Imaging & Diagnostics Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -163.99%
- • Asset Turnover: 1.39x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is below the historical average (0.00%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2009 | 0.00% | -175.95% | 3.60x | 0.00x | $-3.14 Million |
| 2010 | 0.00% | -163.81% | 1.30x | 0.00x | $-3.46 Million |
| 2011 | 0.00% | -253.12% | 0.57x | 0.00x | $-8.99 Million |
| 2012 | 0.00% | -403.38% | 0.94x | 0.00x | $-9.05 Million |
| 2013 | 0.00% | -163.99% | 1.39x | 0.00x | $-4.23 Million |
Industry Comparison
This section compares Caliber Imaging & Diagnostics Inc's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $694,749,556
- Average return on equity (ROE) among peers: -25.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Caliber Imaging & Diagnostics Inc (LCDX) | $-14.18 Million | 0.00% | N/A | $0.93 |
| Advanced Biomedical Technologies Inc (ABMT) | $-4.46 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |